Financhill
Back

Cartesian Therapeutics Stock Predictions

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
70

RNAC
Cartesian Therapeutics

Last Price:
16.94
Seasonality Move:
10.73%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Cartesian Therapeutics Stock Forecast

  • Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 20.7% based on the past 8 years of stock performance.
  • Cartesian Therapeutics has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Cartesian Therapeutics Stock Undervalued?
    The current Cartesian Therapeutics [RNAC] share price is $19.78. The Score for RNAC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • RNAC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Cartesian Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Cartesian Therapeutics has on average historically fallen by 20.7% based on the past 8 years of stock performance.

Cartesian Therapeutics Stock Rating

Buy
70
Cartesian Therapeutics (RNAC) is a Buy

Is Cartesian Therapeutics overpriced?

  • Cartesian Therapeutics has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Cartesian Therapeutics Stock Price History

Is RNAC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cartesiantherapeutics.com

52-Week Data

52-Week High:
42.60
52-Week Low:
11.67

Prediction Charts

Market Cap:
472.67M
Price in USD:
19.78
Volume:
117.54K
Beta:
0.75

Technical Analysis

SMA50:
18.79
SMA100:
17.90
SMA200:
20.16
52-Wk Change:
-31.16%

Stock Predictions

  • Is Cartesian Therapeutics stock public?
    Yes, Cartesian Therapeutics is a publicly traded company.
  • What is the Cartesian Therapeutics stock quote today?
    The Cartesian Therapeutics stock price is 19.78 USD today.
  • How to buy Cartesian Therapeutics stock online?
    You can buy Cartesian Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 21.90 22.18 22.70 21.60
Oct-24 22.33 22.10 23.44 21.54
Oct-25 22.10 20.58 22.78 20.53
Oct-28 20.65 22.30 23.32 20.55
Oct-29 22.32 22.21 22.99 21.45
Oct-30 22.35 21.14 22.90 20.88
Oct-31 21.08 19.69 21.24 18.85
Nov-1 20.17 19.68 20.80 19.16
Nov-4 19.60 19.12 19.82 18.91
Nov-5 19.13 19.80 20.35 19.05
Nov-6 20.68 20.72 21.41 19.91
Nov-7 21.11 20.78 22.20 20.38
Nov-8 21.11 20.76 21.46 20.10
Nov-11 20.87 19.78 21.00 19.25

Cartesian Therapeutics Earnings

Cartesian Therapeutics Earnings Report: Per Share Cartesian Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cartesian Therapeutics Forecast Revenue Growth

Cartesian Therapeutics Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.